PP01.46 Real-world rebiopsy and biomarker retesting rates among patients with non-small cell lung cancer across patient demographics in the United States

2023
Aggarwal C, Xu Q, Ng S, Kamalakar R, Crawford S, Beruti S, Myftiu A, Beasley MB
Read more